Abstracts by keywords: Mental Health
Psychische Erkrankungen haben eine Spitzenposition bezüglich Arbeitsunfähigkeitstagen erreicht. Die entsprechenden Zahlen sind die letzten zwei Jahrzehnte um ca. 250% gestiegen und steigen weiter. Ein Ende des Trends ist nicht abzusehen. Viele Faktoren können für eine solche Entwicklung verantwortlich sein, jedoch ist trotzdem erstaunlich, dass parallel zu dieser Entwicklung auch die Behandlungskosten weit mehr als verdoppelt wurden, sowohl für die Behandlung mit Psychopharmaka als auch für die Behandlung mit Psychotherapie. Laut Weltgesundheitsorganisation WHO wird Depression in Zukunft Rang 2 bezüglich der krankheitsbedingten Beeinträchtigungen (gemäß den DALYs) einnehmen. Dabei stellen Arbeitsunfähigkeitstage nur einen Aspekt der gesellschaftlichen Belastungen durch psychische Erkrankungen dar. Der Produktionsausfall in Betrieben oder Behörden durch Menschen mit psychischen Erkrankungen ist volkswirtschaftlich hochrelevant. Hinzu kommt aber selbstverständlich auch das persönliche Leiden der Betroffenen als zu berücksichtigender Faktor, aber auch der Familien von Betroffenen und des gesamten sozialen Umfelds. Psychische Erkrankungen werden nicht nur durch genetische Faktoren, sondern auch durch die familiäre Belastung häufig an Kinder weitergegeben. Wenn jeder Dritte im Laufe eines Lebens von einer psychischen Erkrankung betroffen sein wird und eine Gesellschaft nicht gut mit psychischen Erkrankungen umgehen kann, hat sie ein grundsätzliches Problem.
05.04.2026
Differences by facility type and relationship with work ability and burnout risk
01.10.2024
Results of a selective literature search
05.06.2023
Since 2020, digital health applications (DiGA or “apps on prescription”) have been offering new perspectives for the German healthcare system. In August 2021, 20 DiGAs had already been successfully tested by the Federal Institute for Drugs and Medical Devices (BfArM) and listed in the directory of prescribable DiGAs. These can now be prescribed and therefore reimbursed by statutory health insurance companies. Ten apps are used to prevent and treat mental illnesses (especially panic disorders and depression). However, there is no app for suicide prevention (Federal Institute for Drugs and Medical Devices).
17.05.2022
Bundeswehr missions abroad have become a piece of normality (Frank Bötel 2016). But these missions are accompanied by stressful experiences for the soldiers and consequences for their mental health. For example, 2.9 % of the soldiers deployed in 2009 as part of the ISAF mission in Afghanistan met the DSM-IV-TR criteria for post-traumatic stress disorder 12 months after the deployment (Wittchen et al. 2012). This 12-month prevalence is not only significantly higher compared to the control soldiers who are not deployed, but also compared to the rates of the age- and gender-adjusted German general population (Jacobi et al. 2014). In addition, it must be feared that the prevalence rates of mental illness after foreign assignments in general (Kang and Hyams 2005), and that of post-traumatic stress disorder (PTSD) in particular (Brewin et al. 2012) will even increase over the years. A key task that not only the Bundeswehr but all those involved in the care of mentally ill people have to face is how to deal with soldiers of the Bundeswehr who have become mentally ill as a result of the deployment (Holtherm 2014). From the point of view of care, the situation is made more difficult by the fact that soldiers, after leaving the Bundeswehr, switch to the civilian German care system, in which the vast majority of service providers no longer have any personal experience with the military system. So far, however, there are no meaningful scientific findings for Germany either on the subjective need for care or on the objective need for care of former soldiers who are now in the civilian health system.
06.12.2017
In addition to care in the acute phase, the guideline-based therapy scheme includes maintenance therapy after the depressive episode has subsided and prophylaxis for future episodes. Psychotherapy and pharmacotherapy are demonstrably effective treatment methods. Of the large number of people with depression requiring treatment, however, only a minority, estimated at less than 10 percent, receive adequate treatment (DGPPN et al. 2015). There are many possible reasons for this: a lack of hope and reduced drive on the part of those affected to get help, delayed diagnosis, deviation from the therapeutic guidelines in everyday family doctor work, and an insufficient range of psychotherapy places and the associated long waiting times. In addition, there are often irrational reservations on the part of those affected or their relatives about antidepressants, shame and stigmatization of the disease in the social environment, etc. This results in an urgent need for action - also for the private insurance industry -, the supply deficits due to inadequate medical supply structures and as a result of the disease and society-related high To lower the access threshold of utilization for the individual patient.